Literature DB >> 7126780

Variations in the relative proportions of microheterogeneous forms of plasma glycoproteins in pregnancy and disease.

J Raynes.   

Abstract

Using lectin affinity crossed immunoelectrophoresis with concanavalin A in the first dimension and electroendosmotic elution with sugar in the second dimension, the microheterogeneity of a range of plasma proteins was examined. Of the five chosen proteins, alpha 1-protease inhibitor and caeruloplasmin displayed complex patterns, with more than four components. Alpha 1-Antichymotrypsin was composed of three or four components whilst alpha 1-acid glycoprotein and alpha 2-HS glycoprotein displayed two, three or four components. The number of components seen in these proteins depended on the serum sample origin. In pregnancy and in patients receiving exogenous aestrogen the relative proportions of the components of all five proteins were altered in the direction of less con A binding; however alpha 1-acid glycoprotein and alpha 1-antichymotrypsin showed the greater change. In acute disorders the proportions of protein components of alpha 1-antichymotrypsin and alpha 1-acid glycoprotein were altered towards a higher level of con A binding components. There is no significant alteration in con A binding associated with the chronic inflammatory response to cancer and rheumatoid arthritis. There was a general reduction of con A binding in all five plasma proteins in conditions when there was a high blood aestrogen level. This decreased affinity for con A was independent of the overall effect of the aestrogen on the serum concentration of the plasma protein. These results suggest that the glycosylation of plasma proteins is probably under the same regulatory system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7126780

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  20 in total

1.  Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels.

Authors:  O Pos; M E van der Stelt; G J Wolbink; M W Nijsten; G L van der Tempel; W van Dijk
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Studies on the interaction between hyaluronan and a rat colon cancer cell line.

Authors:  C Samuelsson; S Gustafson
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

3.  Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines.

Authors:  A Mackiewicz; D Schultz; J Mathison; M Ganapathi; I Kushner
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Serum alpha-thiol protease inhibitor concentrations in health and disease.

Authors:  J R Webb; E H Cooper; M A Forbes
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

Review 5.  Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function.

Authors:  W van Dijk; E C Havenaar; E C Brinkman-van der Linden
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

6.  Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women.

Authors:  J M Pekelharing; E Hepp; J P Kamerling; G J Gerwig; B Leijnse
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

7.  The effects of 17 alpha-ethynyloestradiol and of acute inflammation on the plasma concentration of rat alpha 1-acid glycoprotein and on the induction of its hepatic mRNA.

Authors:  M Diarra-Mehrpour; J Bourguignon; I Leroux-Nicollet; D Marko-Vercaigne; D Biou; M Hiron; J P Lebreton
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

8.  Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein.

Authors:  E C Havenaar; J S Axford; E C Brinkman-van der Linden; A Alavi; E C Van Ommen; B van het Hof; T Spector; A Mackiewicz; W Van Dijk
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

9.  Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitro.

Authors:  A Mackiewicz; M Sobieska; M Kapciñska; S H Mackiewicz; K E Wiktorowicz; T Pawłowski
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

10.  Glycosylation of alpha 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis(x) groups.

Authors:  E C Brinkman-van der Linden; E C van Ommen; W van Dijk
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.